全文获取类型
收费全文 | 1638篇 |
免费 | 51篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 21篇 |
妇产科学 | 26篇 |
基础医学 | 131篇 |
口腔科学 | 12篇 |
临床医学 | 108篇 |
内科学 | 225篇 |
皮肤病学 | 35篇 |
神经病学 | 110篇 |
特种医学 | 108篇 |
外科学 | 618篇 |
综合类 | 2篇 |
预防医学 | 30篇 |
眼科学 | 11篇 |
药学 | 71篇 |
中国医学 | 1篇 |
肿瘤学 | 174篇 |
出版年
2022年 | 16篇 |
2021年 | 23篇 |
2020年 | 17篇 |
2019年 | 16篇 |
2018年 | 26篇 |
2017年 | 18篇 |
2016年 | 23篇 |
2015年 | 26篇 |
2014年 | 35篇 |
2013年 | 27篇 |
2012年 | 35篇 |
2011年 | 60篇 |
2010年 | 36篇 |
2009年 | 26篇 |
2008年 | 53篇 |
2007年 | 48篇 |
2006年 | 54篇 |
2005年 | 63篇 |
2004年 | 63篇 |
2003年 | 50篇 |
2002年 | 59篇 |
2001年 | 65篇 |
2000年 | 63篇 |
1999年 | 60篇 |
1998年 | 28篇 |
1997年 | 16篇 |
1996年 | 32篇 |
1995年 | 27篇 |
1994年 | 15篇 |
1993年 | 11篇 |
1992年 | 47篇 |
1991年 | 48篇 |
1990年 | 42篇 |
1989年 | 50篇 |
1988年 | 60篇 |
1987年 | 57篇 |
1986年 | 46篇 |
1985年 | 54篇 |
1984年 | 32篇 |
1983年 | 32篇 |
1982年 | 9篇 |
1980年 | 6篇 |
1979年 | 19篇 |
1978年 | 8篇 |
1975年 | 7篇 |
1973年 | 7篇 |
1971年 | 8篇 |
1970年 | 7篇 |
1969年 | 12篇 |
1968年 | 10篇 |
排序方式: 共有1691条查询结果,搜索用时 26 毫秒
101.
Ishida H Takeuchi I Ohsawa T Nakada H Ishizuka N Yokoyama M Okita H Inokuma S Suzuki T Yamada H Odaka A Takahama T Murata N Fujioka M Hashimoto D Idezuki Y 《Gan to kagaku ryoho. Cancer & chemotherapy》2000,27(9):1411-1414
A pilot study was performed to evaluate the feasibility and efficacy of irinotecan hydrochloride (CPT-11) plus carboplatin (CBDCA) for treatment of advanced or recurrent colorectal cancer. Fifteen patients with colorectal cancer (nonresectable, 1; noncurative resection, 5; recurrent disease, 9) were treated with CPT-11 (40-50 mg/m2) plus CBDCA (70-100 mg/m2) once a week for 2-3 weeks followed by a one-week rest. This treatment was repeated until disease progression or severe toxic effects were found. The total dose of CPT-11 ranged from 135 to 1,214 (median, 467) mg/m2 and that of CBDCA ranged from 267 to 2,022 (median, 933) mg/m2. Adverse effects included nausea (grade 2) in 2 (13.3%) diarrhea (grade 2) in 2 (13.3%), leukopenia (grade 3) in 2 (13.3%), thrombocytopenia (grade 1) in one (6.7%), and hair falling (grade 3) in one (6.7%). The response rate of 14 evaluable patients was 14.3% (CR, 1; PR,1; NC,7; PD,5). The median survival time of all patients was 405 days from the start of chemotherapy. The survival time of patients with CR, PR, and NC (n = 9) tended to be longer than that of those with PD (n = 5) (p = 0.06). The median time to disease progression was 105 days. These results suggest that this combination chemotherapy is feasible and effective in the treatment of advanced or recurrent colorectal cancer. 相似文献
102.
I Takahashi M Sano H Okamoto M Shiromoto T Nakamura K Ueno H Nakada Y Haruta T Seto J Yamashita 《Acta medica Okayama》1991,45(6):445-449
A 34-year-old woman infected with human T cell leukemia virus type-I(HTLV-I) with recurrent thrombocytopenia and various autoantibodies is described. The platelet counts fluctuated between 1.3 x 10(4)/microliters and 14.8 x 10(4)/microliters without any medical treatment, and thrombocytopenia improved with a decrease of platelet-associated IgG (PA-IgG). Autoantibodies such as rheumatoid factor, antinuclear factor, anti-Sm, anti-RNP and anti-SSA antibodies were also recognized. Marker analysis of peripheral mononuclear cells showed an increase in the proportion of CD 25+ cells, CD 3+ HLA-DR+ cells, CD4+ HLA-DR+ cells and CD8+ HLA-DR+ cells. The recurrent thrombocytopenia and development of various autoantibodies in this HTLV-I carrier are speculated to be due to the alteration of B cell functions by T cells infected with HTLV-I. 相似文献
103.
H Murayama Y Takahara I Nakada Y Sudo T Sezaki T Nakamura 《Kyobu geka. The Japanese journal of thoracic surgery》1989,42(3):229-231
A case of pulmonary artery aneurysm associated with tetralogy of Fallot is presented. A 28-year-old man was admitted for evaluation of cyanosis and cardiac murmur. Preoperative angiography revealed tetralogy of Fallot and an aneurysm of the main pulmonary artery aneurysm. Operation consisted of pulmonary artery aneurysmectomy and total correction of the tetralogy of Fallot. Microscopic examination of the resected aneurysm showed the thickening of intima and fragmented elastic fibers of media. A brief review of the literature emphasizes the necessity of the surgical intervention. 相似文献
104.
105.
Y Okada M Ogawa N Horikoshi J Inagaki K Inoue K Ikeda N Usui H Nakada K Adachi T Mukaiyama 《Gan to kagaku ryoho. Cancer & chemotherapy》1984,11(7):1468-1474
In a total of 277 patients with advanced breast cancer treated between July 1977 and November 1983 at Cancer Institute Hospital, there were 26 cases (9.4%) showing hypercalcemia (Ca greater than or equal to 11.0 mg/dl). All these patients had bone metastasis examined by either X-ray films or bone scintigram during clinical course of the disease and confirmed at the time of autopsy, thus an overall incidence of hypercalcemia in 149 patients with bone metastasis was 17.4%. Major clinical signs due to hypercalcemia were gastrointestinal symptoms such as anorexia, nausea and vomiting, renal dysfunction and neurological symptoms but there was no definitive correlation in between clinical signs and values of serum calcium. Among various treatments performed, a combination of hydration, steroids and calcitonin was the most effective. Mean survival time from the diagnosis of hypercalcemia was 288 + days for responders, and 28.8 days for non-responders (p less than 0.001). Seven patients expired due to hypercalcemia and were died suddenly, while others died of renal failures. 相似文献
106.
T Sakai T Nakada T Kono T Katayama S Masuda 《Hinyokika kiyo. Acta urologica Japonica》1989,35(9):1537-1542
Three cases of epididymal adenomatoid tumor are presented. The adenoid compositions of the tumors lined by epithelial cells showed a canalicular pattern with large vascular spaces, tubular pattern with glandlike regions or plexiform pattern with connective tissue strands. Immunohistochemistry demonstrated positive cytoplasmic staining for keratin, but negative for carcinoembryonic antigen and factor VIII-related antigen in each neoplastic tissue. These findings support the mesothelial origin of the epididymal adenomatoid tumors. 相似文献
107.
108.
Hara T Hirano M Nozawa H Nakada K Hirano Y Oyama K Hada T Takagi T Kikkawa H 《Gan to kagaku ryoho. Cancer & chemotherapy》2005,32(6):829-831
A 48-year-old man underwent subtotal esophagectomy for pStage III (pT 3 pN 3) thoracic esophageal carcinoma on June 20, 2002, in combination with chemotherapy (5-FU 500 mg/day day 1-14, CDDP 10 mg/day day 1-14, VDS 3 mg on days 1 and 8) before and after the operation. Recurrence was seen 7 months after the operation in right pleura and lower mediastinum. Chemo (same regimen)-radiotherapy (50 Gy) was then performed but without effect. Thereafter, lung and upper mediastinal metastases were found, and weekly administration of paclitaxel (70 mg/m2, day 1, 8, 15, q 4w) was initiated in combination with radiotherapy (40 Gy). Two cycles of treatment resulted in PR, and CR was achieved after the 8th cycle was completed. Although treatment was terminated after the 12 th cycle due to development of peripheral neuropathy (grade 2), CR was still maintained 8 months after the completion of treatment. These results suggested the effectiveness of the treatment in cases that show resistance to conventional 5-FU-based chemotherapy. 相似文献
109.
Ishida H Shirakawa K Ohsawa T Hayashi Y Okada N Nakada H Yokoyama M 《Gan to kagaku ryoho. Cancer & chemotherapy》2005,32(9):1295-1299
PURPOSE: To examine the clinical significance of determining the expression levels of DNA topoisomerase- I (topo-I) mRNA of colorectal cancer. METHODS: The relative expression levels of topo-I mRNA in primary colorectal cancer and adjacent normal mucosa were semiquantificated by the RT-PCR method. The relative expression of thymidylate synthase (TS) mRNA of the primary lesions was also examined. RESULTS: The topo- I mRNA expression was higher in the tumorous tissue than in the normal mucosa (n=22, p<0.01). The topo- I mRNA expression did not significantly correlate with 9 clinicopathological variables examined (n=22). In patients who received irinotecan hydrochloride (CPT-11) following the failure of 5-fluorouracil-based treatment, the topoI mRNA expression did not differ nor correlate with the response to CPT-11 (PR, n=14; SD, n=11; PR; n=24) (p=0.91). In these patients, there was no relationship between the topo I mRNA expression and the TS mRNA expression (p=0.22, r=0.18). In addition, the efficacy of CPT-11 did not correlate with combinations subdivided according to the expression levels of topo- I mRNA and TS mRNA. CONCLUSIONS: Determination of topo- I mRNA levels of primary colorectal cancer may not be useful for predicting the efficacy of CPT-11 treatment alone or in combination with TS mRNA levels. 相似文献
110.
Sato S Noguchi Y Wada H Fujita S Nakamura S Tanaka R Nakada T Hasegawa K Nakagawa K Koizumi F Ono T Nouso K Jungbluth A Chen YT Old LJ Shiratori Y Nakayama E 《International journal of oncology》2005,26(1):57-63
We investigated NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and various types of cancer by quantitative real-time RT-PCR. In addition to their high expression in the testis, we observed a low expression of NY-ESO-1 mRNA in the placenta, pancreas and liver, and no expression in 12 other normal tissues. We also observed a low expression of LAGE-1a mRNA in the placenta and ovary, and marginal expression in 13 other normal tissues. In contrast to the previous finding that NY-ESO-1 and LAGE-1a mRNAs were mostly co-expressed in solid tumors, we found an independent expression of NY-ESO-1 and LAGE-1a mRNAs. NY-ESO-1 mRNA expression was mostly associated with LAGE-1a mRNA expression in esophageal and liver cancers, but not in prostate cancer. Immunohistochemistry (IHC) using NY-ESO-1-specific ES121 mAb showed that NY-ESO-1 protein was detected in 6 of 9 and 3 of 10 NY-ESO-1 mRNA-positive specimens from esophageal and liver cancers, respectively. NY-ESO-1 protein expression was correlated with the copy numbers of NY-ESO-1 mRNA. IHC was also performed using ES121 mAb and B9.8 mAb recognizing both NY-ESO-1 and LAGE-1a in 4 esophageal and 6 liver cancer specimens preferentially expressing LAGE-1a mRNA. B9.8-specific staining was observed weakly and focally in one liver cancer specimen expressing >10(5) copies of LAGE-1a mRNA. 相似文献